CD4 and neoplasm: The depletion of CD4+ T cells also diminished the antitumor effect, indicating an important role of CD4+ helper T cells in tumor protection by 2 mAb treatment considering concomitant removal of expanded Treg by anti-CD4 depleting antibody and the key role of Treg in suppressing antitumor immunity [47], [48].